DISC MEDICINE INC's ticker is and the CUSIP is 254604101. A total of 122 filers reported holding DISC MEDICINE INC in Q2 2024. The put-call ratio across all filers is 0.34 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $80,933,776 | -1.3% | 1,795,735 | +36.3% | 8.89% | +34.8% |
| Q1 2024 | $82,009,681 | +6.6% | 1,317,213 | -1.2% | 6.59% | -10.7% |
| Q4 2023 | $76,967,799 | +22.9% | 1,332,545 | 0.0% | 7.38% | +5.4% |
| Q3 2023 | $62,602,964 | +5.8% | 1,332,545 | -0.0% | 7.00% | +14.9% |
| Q2 2023 | $59,165,131 | +140144.9% | 1,332,548 | -33.1% | 6.09% | +15.6% |
| Q1 2023 | $42,187 | – | 1,990,914 | – | 5.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 2,509,456 | $113,101,182 | 11.91% |
| Bain Capital Life Sciences Investors, LLC | 1,795,735 | $80,933,776 | 8.89% |
| Foresite Capital Management V, LLC | 299,069 | $13,479,040 | 8.61% |
| Saturn V Capital Management LP | 503,089 | $22,674,221 | 8.57% |
| Paradigm Biocapital Advisors LP | 2,704,718 | $121,901,640 | 4.66% |
| Ally Bridge Group (NY) LLC | 166,500 | $7,504,155 | 4.47% |
| Frazier Life Sciences Management, L.P. | 1,754,834 | $79,090,368 | 3.70% |
| Logos Global Management LP | 925,000 | $41,689,750 | 3.38% |
| Blue Owl Capital Holdings LP | 215,260 | $9,701,768 | 2.70% |
| Exome Asset Management LLC | 61,000 | $2,749,270 | 2.39% |